TMIC-20VARIATIONS IN ARGINASE 1 EXPRESSION IN GLIOMA-ASSOCIATED MICROGLIA AND MACROPHAGES
Ian Zhang(Universidade Federal do Rio de Janeiro), Behnam Badie(City Of Hope National Medical Center), Hang Gao(Zhejiang Chinese Medical University), Massimo D'appuzo(City of Hope), Leying Zhang(City Of Hope National Medical Center), Darya Alizadeh(CTI BioPharma (United Kingdom)), Junling Liang(Zhejiang University)
Cited by 0
Related Papers
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
|Clinical Cancer Research|2015|754
IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype
|Cancer Immunology Research|2019|437
Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications
|Frontiers in Immunology|2017|216